Medizone Intl. (fka MZEIQ)

[teq0904]

I meant that the bureaucratic FDA has chalked up another industry casualty since mzei couldn't survive long enough to get an approval. Reversing their previous approval years later, and waiting until just after the EPA granted approval comes to mind as a cockroach crushing exercise that the ivory tower eggheads at the FDA specialize in.
Every company I have invested in says their device was well received at the FDA meeting, and why wouldn't mzei get that no strings attached praise since they had all tested their device in advance? Getting through all the bureaucracy and dealing with new blindsided questions years after the process starts, year after review year, that ask for things that everyone already knows are proven is the problem that no amount of well received meetings with the initial FDA review board has any impact on.